VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $311,000 | -5.5% | 9,695 | -13.1% | 0.00% | -20.0% |
| Q3 2021 | $329,000 | -9.4% | 11,159 | +4.4% | 0.01% | 0.0% |
| Q2 2021 | $363,000 | -2.4% | 10,692 | -6.7% | 0.01% | -16.7% |
| Q1 2021 | $372,000 | -44.1% | 11,455 | -38.1% | 0.01% | -45.5% |
| Q4 2020 | $666,000 | -8.6% | 18,502 | -0.6% | 0.01% | -21.4% |
| Q3 2020 | $729,000 | +2.1% | 18,612 | -4.4% | 0.01% | -6.7% |
| Q2 2020 | $714,000 | +41.7% | 19,469 | -10.9% | 0.02% | +25.0% |
| Q1 2020 | $504,000 | -29.9% | 21,856 | -11.0% | 0.01% | -20.0% |
| Q4 2019 | $719,000 | +15.6% | 24,558 | +5.4% | 0.02% | +7.1% |
| Q3 2019 | $622,000 | +640.5% | 23,302 | +536.0% | 0.01% | +600.0% |
| Q3 2017 | $84,000 | -16.8% | 3,664 | -19.6% | 0.00% | -33.3% |
| Q2 2017 | $101,000 | +1.0% | 4,558 | +3.9% | 0.00% | 0.0% |
| Q1 2017 | $100,000 | – | 4,387 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |